Explore why patients stick to expensive brand-name meds over generics. We analyze the psychology, doctor biases, and economic factors driving brand loyalty in healthcare.
Explore the FDA's legal basis for authorizing generic drugs via the Hatch-Waxman Act and ANDA process. Learn how bioequivalence ensures safety while lowering costs for 90% of US prescriptions.
Learn how to navigate insurance rules for generic drug substitution. Understand bioequivalence, state laws, and steps to secure brand-name meds when medically necessary.
Categories